Oncolytics Biotech Inc
(NAS:ONCY)
$
1.07
0 (0%)
Market Cap: 82.02 Mil
Enterprise Value: 64.91 Mil
PE Ratio: 0
PB Ratio: 6.22
GF Score: 37/100 Oncolytics Biotech Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Sep 27, 2023 / 12:35PM GMT
Release Date Price:
$2.23
Carvey Leung
Cantor Fitzgerald - Analyst
Good morning, everyone. My name is Carvey. I'm a research associate here in Cantor. Thank you for joining us, Matt, for our fireside chat.
To start, can you tell us about your role at the company?
Matt Coffey
Oncolytics Biotech Inc. - President and CEO
Yeah. I'm Matt Coffey. I'm the President and CEO. And I was fortunate enough to actually be involved in the discovery team that was involved in the initial discovery that this could potentially act as a cancer therapeutic.
Questions & Answers
Carvey Leung
Cantor Fitzgerald - Analyst
Awesome. Well, thank you for the introduction. What's your company's strategic vision? And where do you see the company, say, in three to five years?
Matt Coffey
Oncolytics Biotech Inc. - President and CEO
We're actually at a very interesting time right now. We have been selected by a non-profit called PanCAN, which is running a Phase 3 for us, and it's an ongoing development
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot